![](/img/cover-not-exists.png)
Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
Xia, Wenle, Gerard, Catherine M, Liu, Leihua, Baudson, Nathalie M, Ory, Thierry L, Spector, Neil LVolume:
24
Year:
2005
Language:
english
Pages:
9
DOI:
10.1038/sj.onc.1208774
File:
PDF, 235 KB
english, 2005